Effects of Chromium Histidinate on Renal Function, Oxidative Stress, and Heat-Shock Proteins in Fat-Fed and Streptozotocin-Treated Rats

Journal of Renal Nutrition

Volumn 20, Issue 2, 2010, Pages 112-120

  Dogukan, Ayhan ^a   Tuzcu, Mehmet ^a   Juturu, Vijaya ^b   Cikim, Gurkan ^c   Ozercan, Ibrahim ^a   Komorowski, James ^b   Sahin, Kazim ^a  

^a FIRAT UNIVERSITY   (Turkey)

^b Nutrition 21 Inc   (United States)

^c Sarahatun Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

8 EPI PROSTAGLANDIN F2ALPHA; 8-EPI-PROSTAGLANDIN F2ALPHA; CHAPERONIN; CHROMIUM HISTIDINATE; DRUG DERIVATIVE; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 70; HISTIDINE; MALONALDEHYDE; ORGANOMETALLIC COMPOUND; PROSTAGLANDIN F2 ALPHA;

ANIMAL; ARTICLE; CHEMISTRY; DIABETIC NEPHROPATHY; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; FAT INTAKE; KIDNEY; LIPID PEROXIDATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PATHOPHYSIOLOGY; RAT; WISTAR RAT;

ANIMALS; CHAPERONIN 60; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIETARY FATS; DINOPROST; HEAT-SHOCK PROTEINS; HISTIDINE; HSP70 HEAT-SHOCK PROTEINS; KIDNEY; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; ORGANOMETALLIC COMPOUNDS; OXIDATIVE STRESS; RATS; RATS, WISTAR;

RATTUS; RATTUS NORVEGICUS;

EID: 76849093541     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2009.04.009     Document Type: Article

References (67)

1. Barnard R.J., Roberts C.K., Varon S.M., and Berger J.J. Diet-induced insulin resistance precedes other aspects of the metabolic syndrome. J Appl Physiol 84 (1998) 1311-1315
2. Buettner R., Schölmerich J., and Bollheimer L.C. High-fat diet: modeling the metabolic disorders of human obesity in rodents. Obesity 15 (2007) 798-808
3. Broadhurst C.L., and Domenico P. Clinical studies on chromium picolinate supplementation in diabetes mellitus-a review. Diabetes Technol Ther 8 (2006) 677-687
4. Bartlett H.E., and Eperjesi F. Nutritional supplementation for type 2 diabetes: a systematic review. Ophthalmic Physiol Opt 28 (2008) 503-523
5. Praga M. Obesity: a neglected culprit in renal disease. Nephrol Dial Transplant 17 (2002) 1157-1159
6. Abrass C.K. Overview: obesity-what does it have to do with kidney disease?. J Am Soc Nephrol 15 (2004) 2768-2772
7. Bagby S.P. Obesity-initiated metabolic syndrome and the kidney: a recipe for chronic kidney disease?. J Am Soc Nephrol 15 (2004) 2775-2791
8. El-Atat F.A., Stas S.N., McFarlane S.I., et al. The relationship between hyperinsulinemia, hypertension and progressive renal disease. J Am Soc Nephrol 15 (2004) 2816-2827
9. Kume S., Uzu T., Araki S., Sugimoto T., et al. Role of altered renal lipid metabolism in the development of renal injury induced by a high-fat diet. J Am Soc Nephrol 18 (2007) 2715-2723
10. Jiang T., Wang Z., Proctor G., et al. Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway. J Biol Chem 280 (2005) 32317-32325
11. Wallach S. Clinical and biochemical aspects of chromium deficiency. J Am Coll Nutr 4 (1985) 107-120
12. Becker D.J., Reul B., Ozeelikay A., et al. Oral selenate improves glucose homeostasis and partly reverses abnormal expression of liver glycolytic and gluconeagenic enzymes in diabetic rats. Diabetologia 39 (1996) 3-11
13. Faure P., Roussel A., Coudray C., Richard M.J., Halimi S., and Favier A. Zinc and insulin sensitivity. Biol Trace Elem Res 32 (1992) 305-310
14. Sahin K., Onderci M., Tuzcu M., et al. Effect of chromium on carbohydrate and lipid metabolism in a rat model of type 2 diabetes mellitus: the fat-fed, streptozotocin-treated rat. Metabolism 56 (2007) 1233-1240
15. Feng W., Ding W., Qian Q., et al. Comparison of the chromium distribution in organs and subcellular fractions of normal and diabetic rats by using enriched stable isotope Cr-50 tracer technique. Biol Trace Elem Res 71 (1999) 121-129
16. Ding W., Chai Z., Duan P., et al. Serum and urine chromium concentrations in elderly diabetics. Biol Trace Elem Res 63 (1998) 231-237
17. Cefalu W.T., Wang Z.Q., Zhang X.H., et al. Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats. J Nutr 132 (2002) 1107-1114
18. Cefalu W.T., and Hu F.B. Role of chromium in human health and in diabetes. Diabetes Care 27 (2004) 2741-2751
19. Watanabe M., Suliman M.E., Qureshi A.R., et al. Consequences of low plasma histidine in chronic kidney disease patients: associations with inflammation, oxidative stress, and mortality. Am J Clin Nutr 87 (2008) 1860-1866
20. Cefalu W.T., Bell-Farrow A.D., Stegner J., et al. Effect of chromium picolinate on insulin sensitivity in vivo. J Trace Elem Exp Med 12 (1999) 71-83
21. Anderson R.A., Polansky M.M., and Bryden N.A. Chromium-histidine complexes as nutrient supplements. US patent issued (February 10, 2004)
22. Anderson R.A., Polansky M.M., and Bryden N.A. Stability and absorption of chromium and absorption of chromium histidinate complexes by humans. Biol Trace Elem Res 101 (2004) 211-218
23. Anderson R.A. Nutritional factors influencing the glucose/insulin system: chromium. J Am Coll Nutr 16 (1997) 404-410
24. Anderson R.A. Chromium, glucose intolerance and diabetes. J Am Coll Nutr 17 (1998) 548-555
25. Reed M.J., Meszaros K., Entes L.J., et al. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism 49 (2000) 1390-1394
26. Karatepe M. Simultaneous determination of ascorbic acid and free malondialdehyde in human serum by HPLC/UV. LC-GC North Am 22 (2004) 362-365
27. Wong Y.T., Ruan R., and Tay F.E.H. Relationship between levels of oxidative DNA damage, lipid peroxidation and mitochondrial membrane potential in young and old F344 rats. Free Radic Res 40 (2006) 393-402
28. Association of Official Analytical Chemists: Official Methods of Analysis, 15th Ed. Arglinton, VA: Association of Official Analytical Chemists, 1990.
29. Lowry O.H., Rosebrough N.J., Farr A.L., et al. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265-275
30. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
31. Baydas G., and Tuzcu M. Protective effects of melatonin against ethanol-induced reactive gliosis in hippocampus and cortex of young and aged rats. Exp Neurol 194 (2005) 175-181
32. Kilic E., Kilic U., Soliz J., Bassetti C.L., Gassmann M., and Hermann D.M. Brain-derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK-1/-2 and Akt pathways. FASEB J 19 (2005) 2026-2028
33. Kilic E., Kilic U., Wang Y., Bassetti C.L., Marti H.H., and Hermann D.M. The phosphatidylinositol-3 kinase/Akt pathway mediates VEGF's neuroprotective activity and induces blood brain barrier permeability after focal cerebral ischemia. FASEB J 20 (2006) 1185-1187
34. Ross M.H., Reith E.J., and Romrell L.J. Histology-A Text and Atlas (1989), Williams and Wilkins, Baltimore
35. SAS Institute. Inc.: SAS User's Guide: Statistics (1999), SAS Institute, Inc., Cary, NC
36. Atalay M., Laaksonen D.E., Niskanen L., et al. Altered antioxidant enzyme defenses in insulin-dependent diabetic men with increased resting and exercise-induced oxidative stress. Acta Physiol Scand 161 (1997) 195-201
37. Ceriello A., Bortolotti N., Falleti E., et al. Total radical trapping antioxidant parameter in NIDDM patients. Diabetes Care 20 (1997) 194-197
38. Atalay M., and Laaksonen D.E. Diabetes, oxidative stress and physical exercise. J Sports Sci Med 1 (2002) 1-14
39. Shinde U.A., and Goyal R.K. Effect of chromium picolinate on histopathological alterations in STZ and neonatal STZ diabetic rats. J Cell Mol Med 7 (2003) 322-329
40. Mita Y., Ishihara K., Fukuchi Y., et al. Supplementation with chromium picolinate recovers renal Cr concentration and improves carbohydrate metabolism and renal function in type 2 diabetic mice. Biol Trace Elem Res 105 (2005) 229-248
41. Cupo M.A., and Donaldson W.E. Chromium and vanadium effects on glucose metabolism and lipid synthesis in the chick. Poult Sci 66 (1987) 120-126
42. Lambert B., and Jacquemin C. Inhibition by insulin of the adrenaline-stimulated adenylate cyclase in rat adipose tissue. FEBS Lett 105 (1979) 19-22
43. Shinde U.A., Sharma G., Xu Y.J., et al. Anti-diabetic activity and mechanism of action of chromium chloride. Exp Clin Endocrinol Diabetes 112 (2004) 248-252
44. Sun Y., Clodfelder B.J., Shute A.A., et al. The biomimetic [Cr(3)O(O(2)CCH(2)CH(3)) (6)(H(2)O)(3)](+) decreases plasma insulin, cholesterol, and triglycerides in healthy and type II diabetic rats but not type I diabetic rats. J Biol Inorg Chem 7 (2002) 852-862
45. Machalinski B., Walczak M., Syrenicz A., et al. Hypoglycemic potency of novel trivalent chromium in hyperglycemic insulin-deficient rats. J Trace Elem Med Biol 20 (2006) 33-39
46. Wang Z.Q., Zhang X.H., Russell J.C., et al. Chromium picolinate enhances skeletal muscle cellular insulin signaling in vivo in obese, insulin-resistant JCR: LA-cp rats. J Nutr 136 (2006) 415-420
47. Sundaram R.K., Bhaskar A., Vijayalingam S., et al. Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications. Clin Sci 90 (1996) 255-260
48. Morrow J.D., Minton T.A., Badr K.F., et al. Evidence that the F2-isoprostane, 8-epi-prostaglandin F2a, is formed in vivo. Biochim Biophys Acta 1210 (1994) 244-248
49. Roberts L.J., and Morrow J.D. Measurement of F2-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 28 (2000) 505-513
50. Moore K. Isoprostane and the liver. Chem Phys Lipids 128 (2004) 125-133
51. Basu S. Oxidative injury induced cyclooxygenase activation in experimental hepatotoxicity. Biochem Biophys Res Commun 254 (1999) 764-767
52. Pratico D., Tangirala R.K., Rader D.J., et al. Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in Apo E-deficient mice. Nat Med 4 (1998) 1189-1192
53. Powers S.K., Locke M., and Demirel H.A. Exercise, heat shock proteins, and myocardial protection from I-R injury. Med Sci Sports Exerc 33 (2001) 386-392
54. Burdon R.H. Heat shock and the heat shock proteins. Biochem J 240 (1986) 313-324
55. Atalay M., Oksala N.K., Laaksonen D.E., et al. Exercise training modulates heat shock protein response in diabetic rats. J Appl Physiol 97 (2004) 605-611
56. Gallaher D.D., Csallany A.S., Shoeman D.W., et al. Diabetes increases excretion of urinary malondehyde conjugates in rats. Lipids 28 (1993) 663-666
57. Preuss H.G., Grojec P.L., Lieberman S., et al. Effects of different chromium compounds on blood pressure and lipid peroxidation in spontaneously hypertensive rats. Clin Nephrol 47 (1997) 325-330
58. Jain S.K., and Lim G. Chromium chloride inhibits TNF-α and IL-6 secretion in isolated human blood mononuclear cells exposed to high glucose. Horm Metab Res 38 (2006) 60-62
59. Jain S.K., and Kannan K. Chromium chloride inhibits oxidative stress and TNF-α secretion caused by exposure to high glucose in cultured monocytes. Biochem Biophys Res Commun 289 (2001) 687-691
60. Jain S.K., Rains J.L., and Croad J.L. Effect of chromium niacinate and chromium picolinate supplementation on lipid peroxidation, TNF-α, IL-6, CRP, glycated hemoglobin, triglycerides and cholesterol levels in blood of streptozotocin-treated diabetic rats. Free Radic Biol Med 43 (2007) 1124-1131
61. Onderci M., Sahin N., Sahin K., et al. The antioxidant properties of chromium and zinc: in vivo effects on digestibility, lipid peroxidation, antioxidant vitamins and some minerals under a low ambient temperature. Biol Trace Elem Res 92 (2003) 139-150
62. Kalant N., and McCormick S. Inhibition by serum components of oxidation and collagen-binding of low-density lipoprotein. Biochim Biophys Acta 1128 (1992) 211-219
63. Pisarenko O.I. Mechanisms of myocardial protection by amino acids: facts and hypotheses. Clin Exp Pharmacol Physiol 23 (1996) 627-633
64. Jensen P.K., Christiansen J.S., Steven K., et al. Renal function in streptozotocin-diabetic rats. Diabetologia 21 (1981) 409-414
65. Dai S., Yuen V.G., Orvig C., et al. Prevention of diabetes-induced pathology in STZ-diabetic rats by bis(maltolato)oxovanadium (IV). Pharmacol Commun 3 (1993) 311-321
66. Rhodes M.C., Hebert C.D., Herbert R.A., et al. Absence of toxic effects in F344/N rats and B6C3F1 mice following subchronic administration of chromium picolinate monohydrate. Food Chem Toxicol 43 (2005) 21-29
67. Mozaffari M.S., Patel C., Ballas C., et al. Effects of chronic chromium picolinate treatment in uninephrectomized rat. Metabolism 54 (2005) 1243-1249